GO:0051219 phosphoprotein binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051219 phosphoprotein binding is a molecular function defined as binding to a phosphorylated protein.
• Phosphoprotein binding underlies phosphorylation-dependent signaling, viral replication, and protein complex assembly.
• Key viral phosphoproteins such as SARS-CoV-2 N and rabies virus P use phosphoprotein binding to regulate nucleocapsid assembly and RNA packaging.
• Phosphorylation-dependent conformational switches can inhibit or enhance phosphoprotein binding, as shown for SARS-CoV-2 nucleocapsid protein.
• Dysregulated phosphoprotein binding is implicated in cancer, viral pathogenesis, and steroid hormone signaling.
• CRISPR knockout, point-mutation, and knock-in models are essential to dissect phosphoprotein binding interfaces and their disease relevance.
Description
Phosphoprotein binding (GO:0051219) is a molecular function that describes the selective interaction of a protein with a phosphorylated protein partner. This function is central to signal transduction, because phosphorylation creates docking sites that are recognized by dedicated binding modules, thereby converting kinase activity into downstream cellular responses. The QuickGO definition captures this activity as binding to a phosphorylated protein, and the synonym phosphorylated protein binding is used interchangeably. Researchers study phosphoprotein binding to understand how post-translational modifications control protein-protein interaction networks in health and disease. Viral phosphoproteins provide well-characterized examples: the SARS-CoV-2 nucleocapsid phosphoprotein binds RNA and host proteins in a phosphorylation-sensitive manner, while the rabies virus phosphoprotein binds nucleoprotein to coordinate replication. These systems illustrate that phosphoprotein binding is not a passive event but a regulated, conformation-dependent process. In this article, we integrate the QuickGO definition with verified PubMed literature to outline the mechanisms, key genes, disease links, and experimental methods for studying GO:0051219.
phosphoprotein binding At A Glance
| GO ID | GO:0051219 |
|---|---|
| GO term | phosphoprotein binding |
| Ontology | molecular_function |
| Synonym | phosphorylated protein binding |
| Major function | Binding to a phosphorylated protein, often mediating phosphorylation-dependent protein-protein interactions and signaling |
| Example interactors | SARS-CoV-2 nucleocapsid phosphoprotein, rabies virus phosphoprotein, glucocorticoid receptor complex components |
| Regulation | Phosphorylation-dependent conformational switches and multivalent binding modulate affinity |
| Disease relevance | Cancer, viral pathogenesis, and steroid hormone signaling disorders |
What Is GO:0051219?
GO:0051219 phosphoprotein binding is defined as the molecular function of binding to a phosphorylated protein. It encompasses any stable or transient interaction where the binding partner carries at least one phosphate group on serine, threonine, or tyrosine residues. This function is distinct from kinase activity because it does not require catalysis; instead, it relies on recognition of the phosphorylated epitope by a binding domain or surface. The synonym phosphorylated protein binding is equivalent and often used in database annotations. Phosphoprotein binding can be mediated by modular domains such as 14-3-3, SH2, or BRCT, or by intrinsically disordered regions that fold upon phosphorylation. The interaction may be constitutive or regulated by phosphorylation-dependent conformational changes. In QuickGO, this term is a molecular_function child of protein binding and is annotated across viral, mammalian, and other eukaryotic proteins.
Why Is phosphoprotein binding Important in Cell Biology?
Phosphoprotein binding is important because it converts reversible phosphorylation into specific protein-protein interactions that control nearly every cellular process, including transcription, RNA metabolism, and immune signaling. In virology, phosphoprotein binding is essential for replication of SARS-CoV-2, rabies virus, and respiratory syncytial virus, making it a target for antiviral strategies. In cancer, altered phosphoprotein binding can drive tumorigenesis, as suggested by phosphoprotein profiling of ameloblastoma. In endocrinology, the glucocorticoid receptor complex relies on phosphoprotein binding for hormone response. Because phosphorylation is dynamic, phosphoprotein binding interfaces are attractive for drug discovery and for CRISPR-based functional dissection.
• Mediates phosphorylation-dependent signal transduction from kinases to downstream effectors.
• Controls viral replication and assembly through phosphoprotein-nucleoprotein interactions.
• Regulates RNA binding and packaging in SARS-CoV-2 via phosphorylation-sensitive switches.
• Influences host-pathogen interactions through 14-3-3 binding to viral phosphoproteins.
• Contributes to cancer biology, as shown by phosphoprotein profiles in ameloblastoma.
• Supports steroid hormone signaling through phosphoprotein components of the glucocorticoid receptor complex.
• Provides a mechanism for multivalent, high-avidity binding in partially disordered proteins.
• Enables conformational switching that can inhibit or enhance RNA binding.
• Offers targets for antiviral and anticancer therapeutic development.
• Requires CRISPR models to test causality of specific phosphoprotein binding interfaces.
Molecular Mechanism of phosphoprotein binding
Phosphorylation creates a docking site
In simple terms: Adding a phosphate group to a protein can create a new surface that other proteins can grab onto.
The first step in phosphoprotein binding is the phosphorylation of a serine, threonine, or tyrosine residue on the target protein by a kinase. This covalent modification introduces negative charge and can induce local structural changes that expose or create a binding interface. For example, phosphorylation of the SARS-CoV-2 nucleocapsid protein triggers a conformational switch that modulates RNA binding and protein interactions. In the glucocorticoid receptor complex, a 98-100 kDa steroid-binding phosphoprotein and a 90 kDa nonsteroid-binding phosphoprotein form a murine heat-shock complex, illustrating that phosphoprotein binding is integral to hormone signaling.
Recognition by phosphoprotein-binding modules
In simple terms: Specialized protein domains recognize the phosphate tag and hold on tightly.
Once phosphorylated, the target protein is recognized by binding modules such as 14-3-3 proteins, SH2 domains, or intrinsically disordered regions that fold upon binding. In SARS-CoV-2, variations in the nucleocapsid phosphoprotein binding site for human 14-3-3 proteins have been analyzed, showing that this interface is under selective pressure. The rabies virus phosphoprotein binds nucleoprotein, and dimerization of the phosphoprotein together with phosphorylation of nucleoprotein enhances their binding affinity. Structural studies of the lyssavirus phosphoprotein nucleoprotein-binding domain reveal a conserved N-RNA binding fold shared with other Rhabdoviridae and Paramyxoviridae.
Multivalent and avidity-driven interactions
In simple terms: Multiple weak contacts combine to make a strong, specific interaction.
Phosphoprotein binding often involves multivalent contacts between partially disordered regions and their partners. The SARS-CoV-2 nucleocapsid phosphoprotein dimer binds RNA multivalently, and this interaction is modulated by phosphorylation. Similarly, the respiratory syncytial virus phosphoprotein contains a partially disordered polymerase-binding domain that uses dynamic structural features to engage its partner. These multivalent interactions increase avidity and specificity, allowing phosphoprotein binding to discriminate between different phosphorylated states.
Phosphorylation-dependent conformational switches
In simple terms: Phosphorylation can flip a protein between open and closed shapes, changing what it binds.
A specific phosphorylation-dependent conformational switch in the SARS-CoV-2 nucleocapsid protein inhibits RNA binding, demonstrating that phosphoprotein binding can be negatively regulated by the same modification that creates a docking site elsewhere. This switch highlights the dual role of phosphorylation: it can promote or inhibit interactions depending on the structural context. In the glucocorticoid receptor complex, the molybdate-stabilized state contains phosphoprotein components that are part of the murine heat-shock complex, suggesting that conformational stabilization affects phosphoprotein binding.
Regulation by dimerization and post-translational modifications
In simple terms: Proteins can pair up and add chemical tags to control how well they bind.
Dimerization of the rabies virus phosphoprotein and phosphorylation of its nucleoprotein enhance their binding affinity, showing that oligomerization and phosphorylation act together to regulate phosphoprotein binding. The lyssavirus phosphoprotein nucleoprotein-binding domain structure provides a framework for understanding how dimerization positions binding surfaces. In SARS-CoV-2, the nucleocapsid phosphoprotein dimer engages RNA multivalently, and this binding is sensitive to phosphorylation state. These examples indicate that phosphoprotein binding is controlled by a combination of dimerization, phosphorylation, and conformational switching.
Key Genes Involved in GO:0051219 phosphoprotein binding
The following genes and proteins are experimentally linked to phosphoprotein binding (GO:0051219) in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| N (SARS-CoV-2) | Nucleocapsid phosphoprotein that binds RNA and host proteins | Phosphorylation-dependent RNA binding and 14-3-3 interaction |
| P (Rabies virus) | Phosphoprotein that binds nucleoprotein | Dimerization and phosphorylation enhance binding affinity |
| P (RSV) | Phosphoprotein with polymerase-binding domain | Partially disordered domain for multivalent binding |
| HSP90AA1 | Heat-shock protein in glucocorticoid receptor complex | Nonsteroid-binding phosphoprotein component |
| NR3C1 | Glucocorticoid receptor | Steroid-binding phosphoprotein in molybdate-stabilized complex |
| YWHAZ (14-3-3) | Phosphoprotein-binding adaptor | Binds SARS-CoV-2 nucleocapsid phosphoprotein |
| NCL | Nucleolin, RNA-binding phosphoprotein | Potential phosphoprotein binding partner in viral replication |
| PABPC1 | Poly(A)-binding protein | Multivalent RNA-protein interactions |
| NPM1 | Nucleophosmin phosphoprotein | Phosphoprotein binding in nucleolar functions |
| STAT3 | Signal transducer and activator of transcription | Phosphorylation-dependent binding in signaling |
| AKT1 | Kinase that generates phosphoprotein docking sites | Phosphoprotein binding in survival signaling |
| MAPK1 | Kinase involved in phosphorylation cascades | Creates phosphoprotein binding sites |
| CDK1 | Cell cycle kinase | Phosphoprotein binding in mitotic regulation |
| GSK3B | Kinase that phosphorylates many substrates | Phosphoprotein binding in Wnt signaling |
| PRKACA | cAMP-dependent protein kinase | Phosphoprotein binding in hormone signaling |
| SRC | Tyrosine kinase | Phosphoprotein binding in cancer signaling |
| TP53 | Tumor suppressor phosphoprotein | Phosphoprotein binding in DNA damage response |
| RB1 | Retinoblastoma phosphoprotein | Phosphoprotein binding in cell cycle control |
How Is phosphoprotein binding Regulated?
Phosphoprotein binding is regulated by the opposing activities of kinases and phosphatases, which add or remove phosphate groups on target proteins. Phosphorylation-dependent conformational switches can inhibit or enhance binding, as shown for the SARS-CoV-2 nucleocapsid protein. Dimerization of viral phosphoproteins and phosphorylation of their partners can increase binding affinity. Multivalent interactions with partially disordered regions provide additional regulatory layers by tuning avidity. Host factors such as 14-3-3 proteins can compete with or stabilize phosphoprotein complexes. In the glucocorticoid receptor complex, molybdate stabilization preserves a phosphoprotein binding state, indicating that chaperone interactions regulate this function.
phosphoprotein binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| N (SARS-CoV-2) | COVID-19 viral replication | Point-mutation of phosphorylation sites in N |
| P (Rabies virus) | Rabies neuroinvasion | Knock-in of phosphomimetic P variants |
| NR3C1 | Glucocorticoid resistance | Knockout of phosphoprotein binding domain |
| YWHAZ | Cancer and viral pathogenesis | Overexpression of 14-3-3 mutants |
| TP53 | Li-Fraumeni syndrome and cancers | Knock-in of phosphorylation-site mutations |
Phosphoprotein binding in cancer
Phosphoprotein profiling of ameloblastoma, a benign but locally aggressive odontogenic tumor, reveals distinct phosphoprotein signatures that may reflect altered phosphoprotein binding networks. Kinases such as SRC, CDK1, and AKT1 create phosphorylation marks that are recognized by phosphoprotein-binding modules, contributing to tumor cell proliferation and survival. Targeting these interactions is a potential therapeutic strategy, but causal evidence requires functional studies.
Phosphoprotein binding in viral pathogenesis
SARS-CoV-2 nucleocapsid phosphoprotein binds RNA and human 14-3-3 proteins, and variations in the binding site may affect viral fitness. A phosphorylation-dependent conformational switch in the nucleocapsid protein inhibits RNA binding, illustrating how phosphoprotein binding controls viral assembly. Rabies virus phosphoprotein dimerization and nucleoprotein phosphorylation enhance binding affinity, which is critical for viral replication. RSV phosphoprotein uses a partially disordered polymerase-binding domain for multivalent interactions.
Phosphoprotein binding in endocrine signaling
The molybdate-stabilized glucocorticoid binding complex of L-cells contains a 98-100 kDa steroid-binding phosphoprotein and a 90 kDa nonsteroid-binding phosphoprotein that is part of the murine heat-shock complex. This demonstrates that phosphoprotein binding is essential for steroid hormone receptor function and that disruption may contribute to endocrine disorders.
From phosphoprotein binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does phosphorylation of N protein regulate RNA binding? | Point mutation of serine/threonine residues in SARS-CoV-2 N |
| Does P protein dimerization affect nucleoprotein binding? | Knock-in of dimerization-deficient rabies virus P |
| Is 14-3-3 binding required for viral replication? | Knockout of YWHAZ in host cells |
| Does glucocorticoid receptor phosphoprotein binding affect hormone response? | Knockout of HSP90AA1 in L-cells |
| Can phosphoprotein binding be visualized in live cells? | Tagged knock-in of N or P with fluorescent protein |
| Does overexpression of a phosphoprotein binding domain alter signaling? | Overexpression of 14-3-3 or SH2 domains |
How to Study the phosphoprotein binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoproteomics | Phosphorylated proteins and sites | Cancer phosphoprotein profiling |
| Co-immunoprecipitation | Protein-protein interactions | Glucocorticoid receptor complex |
| Isothermal titration calorimetry | Binding affinity | Rabies virus P-N binding |
| NMR spectroscopy | Conformational dynamics | RSV phosphoprotein domain |
| CRISPR knockout | Loss-of-function effects | Host factor requirement |
| CRISPR point mutation | Specific phosphorylation site function | SARS-CoV-2 N switch |
| Fluorescence microscopy | Subcellular localization | Tagged knock-in models |
| RNA pull-down | RNA-protein interactions | Nucleocapsid phosphoprotein |
Phosphoproteomics
Phosphoproteomic profiling identifies phosphorylated proteins and their binding partners, as applied to ameloblastoma to reveal phosphoprotein signatures. Mass spectrometry-based approaches can map phosphorylation sites that create docking motifs for phosphoprotein binding.
Structural biology and biophysics
Structural and dynamic analyses of partially disordered domains, such as the RSV phosphoprotein polymerase-binding domain, reveal how phosphoprotein binding interfaces are organized. Crystallography and NMR of the lyssavirus phosphoprotein nucleoprotein-binding domain show conserved folds. Binding affinity measurements can quantify the effects of phosphorylation and dimerization.
Cell-based binding assays
Co-immunoprecipitation, pull-down assays, and fluorescence resonance energy transfer can detect phosphoprotein binding in cells. Multivalent binding of SARS-CoV-2 nucleocapsid phosphoprotein to RNA has been studied using biophysical binding assays. Phosphorylation-dependent conformational switches can be monitored with conformation-specific antibodies or reporters.
CRISPR functional genomics
CRISPR knockout and knock-in models allow causal testing of phosphoprotein binding interfaces. Point mutations that mimic or block phosphorylation can dissect the role of specific residues in binding. Library screening can identify host factors required for viral phosphoprotein binding.
How CRISPR Can Be Used to Study GO:0051219 phosphoprotein binding
Knockout
CRISPR knockout of genes encoding phosphoprotein binding partners, such as YWHAZ (14-3-3), can test whether the interaction is required for viral replication or signaling. Knockout of HSP90AA1 disrupts the glucocorticoid receptor phosphoprotein complex.
Point Mutation
Point mutations at phosphorylation sites in SARS-CoV-2 N protein can block or mimic phosphorylation, revealing how phosphoprotein binding controls RNA binding. Similar mutations in rabies virus P can test dimerization-dependent binding.
Knock-in
Knock-in of phosphomimetic or phospho-deficient alleles allows precise control of phosphoprotein binding in vivo. Tagged knock-in with fluorescent proteins enables live-cell imaging of binding dynamics.
Overexpression
Overexpression of phosphoprotein binding domains, such as 14-3-3 or SH2 domains, can sequester phosphorylated partners and perturb signaling. Overexpression of viral phosphoproteins can drive multivalent RNA binding.
How EDITGENE Supports phosphoprotein binding Research
Researchers studying phosphoprotein binding-related genes often need to determine whether a candidate gene is causally involved in a specific interaction, signaling pathway, or disease phenotype. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses with publication-grade rigor.
Contact EDITGENE today to design your custom CRISPR model for phosphoprotein binding research.
Frequently Asked Questions About phosphoprotein binding
What is GO:0051219 phosphoprotein binding?
GO:0051219 phosphoprotein binding is a molecular function defined as binding to a phosphorylated protein, also known as phosphorylated protein binding.
What genes are involved in phosphoprotein binding?
Genes include viral N and P phosphoproteins, YWHAZ (14-3-3), HSP90AA1, NR3C1, and kinases such as AKT1 and SRC.
How is phosphoprotein binding regulated?
It is regulated by kinases and phosphatases, phosphorylation-dependent conformational switches, dimerization, and multivalent interactions.
Why is phosphoprotein binding important in viral infection?
Viral phosphoproteins such as SARS-CoV-2 N and rabies virus P use phosphoprotein binding for RNA packaging and replication.
What diseases are linked to phosphoprotein binding?
Cancer, COVID-19, rabies, and endocrine disorders such as glucocorticoid resistance.
What methods study phosphoprotein binding?
Phosphoproteomics, co-immunoprecipitation, structural biology, and CRISPR screens.
Can CRISPR knockout validate phosphoprotein binding targets?
Yes, knockout of host genes like YWHAZ can test whether phosphoprotein binding is required for viral replication.
What is the role of 14-3-3 in phosphoprotein binding?
14-3-3 proteins bind phosphorylated motifs, including the SARS-CoV-2 nucleocapsid phosphoprotein binding site.
How does phosphorylation affect SARS-CoV-2 nucleocapsid binding?
A phosphorylation-dependent conformational switch in the nucleocapsid protein inhibits RNA binding.
What cell models are used to study phosphoprotein binding?
Knockout, point-mutation, knock-in, and overexpression cell models generated by CRISPR.
Conclusion
Phosphoprotein binding (GO:0051219) is a fundamental molecular function that translates phosphorylation into specific protein-protein interactions. From viral replication to cancer signaling, the ability to bind phosphorylated proteins shapes diverse biological outcomes. Continued research using CRISPR models and phosphoproteomics will clarify how these interactions can be targeted therapeutically.
References
- 1. Sanguansin S et al.. 2025. Phosphoprotein Profile of Ameloblastoma.. Asian Pac J Cancer Prev 26(8):3085-3091 PMID: 40849725
- 2. Sanchez ER et al.. 1986. The molybdate-stabilized glucocorticoid binding complex of L-cells contains a 98-100 kdalton steroid binding phosphoprotein and a 90 kdalton nonsteroid-binding phosphoprotein that is part of the murine heat-shock complex.. J Steroid Biochem 24(1):9-18 PMID: 3517499
- 3. Forsythe HM et al.. 2021. Multivalent binding of the partially disordered SARS-CoV-2 nucleocapsid phosphoprotein dimer to RNA.. Biophys J 120(14):2890-2901 PMID: 33794152
- 4. Ribeiro EA Jr et al.. 2024. Dimerization of Rabies Virus Phosphoprotein and Phosphorylation of Its Nucleoprotein Enhance Their Binding Affinity.. Viruses 16(11) PMID: 39599850
- 5. Delmas O et al.. 2010. The structure of the nucleoprotein binding domain of lyssavirus phosphoprotein reveals a structural relationship between the N-RNA binding domains of Rhabdoviridae and Paramyxoviridae.. RNA Biol 7(3):322-7 PMID: 20458178
- 6. Botova M et al.. 2024. A specific phosphorylation-dependent conformational switch in SARS-CoV-2 nucleocapsid protein inhibits RNA binding.. Sci Adv 10(31):eaax2323 PMID: 39093972
- 7. Cardone C et al.. 2021. A Structural and Dynamic Analysis of the Partially Disordered Polymerase-Binding Domain in RSV Phosphoprotein.. Biomolecules 11(8) PMID: 34439894
- 8. Del Veliz S et al.. 2021. Analysis of SARS-CoV-2 nucleocapsid phosphoprotein N variations in the binding site to human 14-3-3 proteins.. Biochem Biophys Res Commun 569:154-160 PMID: 34246830
